Dynavax Technologies Corporation (Nasdaq: DVAX), a commercial-stage biopharmaceutical company developing and commercializing innovative vaccines, and Vaxart, Inc. (OTCQX: VXRT), a clinical-stage ...

Article Summary Illinois lawmakers passed 24 bills during the two-week fall veto session. House Bill 767 would allow IDPH Director ...

Through his leadership at the FDA's Center for Biologics Evaluation and Research (CBER), Vinay Prasad, MD, MPH has pushed out at least 7 senior leaders and created an environment that employees worry ...

About 1 in 4 American adults got a covid vaccine shot during the 2024-25 virus season, a fraction health care experts warn ...

"This is very exciting," says one infectious disease doctor. The new RSV vaccines were approved in 2023—and today’s research ...

The Cornwall and Isles of Scilly Commercial Research Delivery Centre (CIOS CRDC) said it was selected as a delivery site for ...

The fall COVID-19 vaccine season is starting slowly for Pfizer, with U.S. sales of its Comirnaty shots sinking 25% after federal regulators narrowed recommendations on who should get them.

Natasha Smith has seen her views on vaccines transform. “I had been reading books about pregnancy and parenthood of toddlers, ...

A growing number of FDA employees are eyeing the exits as chaos and uncertainty sweep through the agency, according to ...

Taking a closer look at the numbers, Comirnaty sales slipped 19% globally to $1.15 billion, the Prevnar franchise experienced a 3% global sales decline to $1.7 billion, and Abrysvo’s performance ...

An alleged extortion attempt, a petty yearslong grudge, shocking social media posts, and ominous text messages make up the ...

CSL has used the first session of its capital markets fiesta in Chicago to assure investors the company has a flu vaccine ...